Vontobel Asset Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $788M | Sell |
3,441,197
-215,382
| -6% | -$45.2M | 4.36% | 5 |
|
|
2023
Q4 | $811M | Sell |
3,656,579
-318,274
| -8% | -$67.9M | 4.82% | 6 |
|
|
2023
Q3 | $854M | Sell |
3,974,853
-34,000
| -0.8% | -$6.76M | 5.54% | 2 |
|
|
2023
Q2 | $794M | Buy |
4,008,853
+46,800
| +1% | +$8.65M | 5.26% | 5 |
|
|
2023
Q1 | $814M | Buy |
3,962,053
+133,897
| +3% | +$24.2M | 5.88% | 2 |
|
|
2022
Q4 | $690M | Buy |
3,828,156
+79,762
| +2% | +$13.9M | 5.49% | 4 |
|
|
2022
Q3 | $726M | Sell |
3,748,394
-101,812
| -3% | -$20.1M | 5.74% | 5 |
|
|
2022
Q2 | $841M | Buy |
3,850,206
+116,894
| +3% | +$24.8M | 6.15% | 5 |
|
|
2022
Q1 | $930M | Sell |
3,733,312
-384,929
| -9% | -$90.4M | 6.16% | 4 |
|
|
2021
Q4 | $986M | Buy |
4,118,241
+50,549
| +1% | +$11.1M | 5.79% | 3 |
|
|
2021
Q3 | $818M | Buy |
4,067,692
+59,267
| +1% | +$12M | 4.6% | 5 |
|
|
2021
Q2 | $881M | Buy |
4,008,425
+1,178,784
| +42% | +$249M | 4.52% | 6 |
|
|
2021
Q1 | $600M | Buy |
2,829,641
+865,745
| +44% | +$171M | 3.65% | 8 |
|
|
2020
Q4 | $371M | Buy |
1,963,896
+575,336
| +41% | +$97.8M | 2.19% | 19 |
|
|
2020
Q3 | $244M | Buy |
1,388,560
+615,899
| +80% | +$104M | 1.47% | 28 |
|
|
2020
Q2 | $133M | Buy |
772,661
+74,783
| +11% | +$13.4M | 0.89% | 36 |
|
|
2020
Q1 | $130M | Sell |
697,878
-448,608
| -39% | -$89.3M | 0.98% | 37 |
|
|
2019
Q4 | $242M | Sell |
1,146,486
-336,277
| -23% | -$69M | 1.54% | 25 |
|
|
2019
Q3 | $332M | Sell |
1,482,763
-13,140
| -0.9% | -$2.75M | 2.23% | 20 |
|
|
2019
Q2 | $300M | Sell |
1,495,903
-327,611
| -18% | -$60.4M | 2.25% | 15 |
|
|
2019
Q1 | $310M | Sell |
1,823,514
-197,444
| -10% | -$34.9M | 2.48% | 15 |
|
|
2018
Q4 | $394M | Buy |
2,020,958
+67,532
| +3% | +$12.5M | 3.39% | 10 |
|
|
2018
Q3 | $343M | Buy |
1,953,426
+387,076
| +25% | +$65.2M | 2.6% | 13 |
|
|
2018
Q2 | $264M | Buy |
1,566,350
+195,430
| +14% | +$31.9M | 1.96% | 17 |
|
|
2018
Q1 | $226M | Buy |
1,370,920
+1,110,586
| +427% | +$177M | 1.62% | 23 |
|
|
2017
Q4 | $38M | Buy |
260,334
+145,285
| +126% | +$20.7M | 0.27% | 47 |
|
|
2017
Q3 | $15.6M | Sell |
115,049
-2,619
| -2% | -$331K | 0.11% | 53 |
|
|
2017
Q2 | $14.7M | Sell |
117,668
-33,612
| -22% | -$4.02M | 0.11% | 52 |
|
|
2017
Q1 | $18M | Hold |
151,280
| – | – | 0.15% | 44 |
|
|
2016
Q4 | $17.4M | Hold |
151,280
| – | – | 0.15% | 48 |
|
|
2016
Q3 | $15.8M | Sell |
151,280
-1,453,862
| -91% | -$152M | 0.12% | 52 |
|
|
2016
Q2 | $163M | Sell |
1,605,142
-340,148
| -17% | -$32.1M | 1.32% | 33 |
|
|
2016
Q1 | $194M | Buy |
1,945,290
+90,413
| +5% | +$8.23M | 1.5% | 28 |
|
|
2015
Q4 | $178M | Buy |
1,854,877
+119,379
| +7% | +$11.2M | 1.37% | 26 |
|
|
2015
Q3 | $171M | Buy |
1,735,498
+787,592
| +83% | +$74.9M | 1.46% | 26 |
|
|
2015
Q2 | $92.2M | Buy |
+947,906
| New | +$88.4M | 0.7% | 40 |
|
Other funds holding CME
Vontobel Asset Management's CME Position: Q1 2024 in Review
Vontobel Asset Management reduced its CME Group (CME) stake by 5.9% in Q1 2024, selling an estimated $45.2M and leaving 3,441,197 shares worth $788M. The position accounts for 4.36% of the portfolio, ranked #5.
Vontobel Asset Management first reported a position in CME in Q2 2015 and has held it in 36 quarters since. The position peaked at $986M in Q4 2021. 1,372 funds tracked by Wall St. Rank hold CME as of Q1 2024.
- Vontobel Asset Management held 3,441,197 shares of CME Group worth $788M as of Q1 2024.
- Vontobel Asset Management sold 215,382 CME Group shares in Q1 2024, an estimated $45.2M.
- CME Group made up 4.36% of Vontobel Asset Management's portfolio in Q1 2024, its #5 holding.
- Vontobel Asset Management first reported a position in CME Group in Q2 2015 and has held it in 36 quarters since.
- Vontobel Asset Management's CME Group position peaked at $986M in Q4 2021.
- 1,372 funds tracked by Wall St. Rank held CME Group as of Q1 2024.
Based on Vontobel Asset Management's 13F filing for Q1 2024, filed 15 May 2024.